ANPEP and pachyonychia congenita: ROC analysis determined that serum APN/CD13 levels >49.9 U/mL predicted one-year mortality in PC patients with 87.9% sensitivity and 79.4% specificity (AUC: 0.877, 95% CI: 0.824–0.931; Supplementary Figure S2).